(Q33402005)

English

Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

0 references

expression library

1 reference

based on heuristic

inferred from title

object named as

Valeria Tekiel

1

0 references

author name string

Catalina D Alba-Soto

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stella M González Cappa

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Miriam Postan

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniel O Sánchez

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

20 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1323-1332

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kinetoplastids: related protozoan pathogens, different diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Current status and future prospects for a vaccine against American trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Protective Immunity Against Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain After Vaccination with Genes Encoding the Amastigote Surface Protein-2 and Trans-Sialidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Utilization of genomic sequence information to develop malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Expression library immunization to discover and improve vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Identification of a protective antigen of Coccidioides immitis by expression library immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Expression library immunization confers partial protection against Chlamydia muridarum genital infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Screening the whole genome of a pathogen in vivo for individual protective antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Expression library immunization: a road map for discovery of vaccines against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Chagas' disease: TCRBV9 over-representation and sequence oligoclonality in the fine specificity of T lymphocytes in target tissues of damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Generation and analysis of expressed sequence tags from Trypanosoma cruzi trypomastigote and amastigote cDNA libraries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

TcruziDB: an integrated, post-genomics community resource for Trypanosoma cruzi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Adjuvant formulations and delivery systems for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Sequence diversity of the Trypanosoma cruzi complement regulatory protein family

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Identification of a universal Group B streptococcus vaccine by multiple genome screen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

based on heuristic

inferred from DOI database lookup

Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Immune system recognition of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

The LAMP-like protein p67 plays an essential role in the lysosome of African trypanosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Molecular cloning of p67, a lysosomal membrane glycoprotein from Trypanosoma brucei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.056

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.12.056

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33402005&oldid=2121732517"